188 related articles for article (PubMed ID: 8665481)
1. Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells.
Miniati DN; Chang Y; Shu WP; Peehl DM; Liu BC
Cancer Lett; 1996 Jul; 104(2):137-44. PubMed ID: 8665481
[TBL] [Abstract][Full Text] [Related]
2. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
[TBL] [Abstract][Full Text] [Related]
3. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
Kim IY; Zelner DJ; Lee C
Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
[TBL] [Abstract][Full Text] [Related]
4. Regulation of prostatic carcinoma cell proliferation and secretory activity by extracellular matrix and stromal secretions.
Fong CJ; Sherwood ER; Braun EJ; Berg LA; Lee C; Kozlowski JM
Prostate; 1992; 21(2):121-31. PubMed ID: 1384014
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
[TBL] [Abstract][Full Text] [Related]
6. Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: role of heparin/heparan-degrading enzymes.
Kassen AE; Sensibar JA; Sintich SM; Pruden SJ; Kozlowski JM; Lee C
Prostate; 2000 Jul; 44(2):124-32. PubMed ID: 10881022
[TBL] [Abstract][Full Text] [Related]
7. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.
Lee C; Sutkowski DM; Sensibar JA; Zelner D; Kim I; Amsel I; Shaw N; Prins GS; Kozlowski JM
Endocrinology; 1995 Feb; 136(2):796-803. PubMed ID: 7530653
[TBL] [Abstract][Full Text] [Related]
8. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
10. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
Thelen P; Jarry H; Ringert RH; Wuttke W
Planta Med; 2004 May; 70(5):397-400. PubMed ID: 15124082
[TBL] [Abstract][Full Text] [Related]
11. Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix.
Guo Y; Pili R; Passaniti A
Prostate; 1994; 24(1):1-10. PubMed ID: 7507237
[TBL] [Abstract][Full Text] [Related]
12. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone.
McCulloch DR; Harvey M; Herington AC
Mol Cell Endocrinol; 2000 Sep; 167(1-2):11-21. PubMed ID: 11000516
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
[TBL] [Abstract][Full Text] [Related]
14. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
[TBL] [Abstract][Full Text] [Related]
15. Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells.
Lin MF; Garcia-Arenas R; Chao YC; Lai MM; Patel PC; Xia XZ
Arch Biochem Biophys; 1993 Jan; 300(1):384-90. PubMed ID: 8424672
[TBL] [Abstract][Full Text] [Related]
16. Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line.
Kirschenbaum A; Ren M; Levine AC
Steroids; 1993 Sep; 58(9):439-44. PubMed ID: 8236330
[TBL] [Abstract][Full Text] [Related]
17. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells.
Bruckheimer EM; Kyprianou N
Endocrinology; 2001 Jun; 142(6):2419-26. PubMed ID: 11356690
[TBL] [Abstract][Full Text] [Related]
18. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines.
Blanchère M; Saunier E; Mestayer C; Broshuis M; Mowszowicz I
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):297-304. PubMed ID: 12589936
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
Sherwood ER; Van Dongen JL; Wood CG; Liao S; Kozlowski JM; Lee C
Br J Cancer; 1998 Mar; 77(6):855-61. PubMed ID: 9528825
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
Dulińska J; Laidler P; Labedź M
Acta Biochim Pol; 2002; 49(2):357-68. PubMed ID: 12362977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
